Presented ByProf. Naveen Pemmaraju, MD Anderson Cancer Center, TX, USA
TrialPhase 3, TRANSFORM-1 ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 14:28
Presented ByDr Raajit Rampal, Memorial Sloan Kettering Cancer Center, NY, USA
TrialPhase 3, MANIFEST-2 ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 14:28
Presented ByProf. Martina Porter, Beth Israel Deaconess Medical Center, MA, USA
TrialPhase 2 ConferenceAAD 2024
TypePeer-reviewed article
22 April 2024 16:16
Presented ByProf. Naveen Pemmaraju, MD Anderson Cancer Center, TX, USA
TrialPhase 3, TRANSFORM-1 ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 14:57
Presented ByDr Albert Wolkerstorfer, Amsterdam University Medical Centers, the Netherlands
TrialPhase 3, TRuE-V1; TRuE-V1 ConferenceEADV 2023
TypePeer-reviewed article
28 November 2023 11:10
Presented ByProf. Ronjon Chakraverty, University of Oxford, UK
ConferenceEBMT 2023
TypePeer-reviewed article
15 June 2023 16:54
Presented ByDr Andrew Blauvelt, Oregon Medical Research Center, OR, USA
TrialPhase 3, TRuE-AD1 and TRuE-AD2 ConferenceAAD 2023
TypePeer-reviewed article
15 May 2023 11:43
Presented ByProf. John Harris, UMass Chan Medical School, MA, USA
ConferenceAAD 2023
TypePeer-reviewed article
15 May 2023 10:51
Presented ByDr Brett King, Yale University, CT, USA
ConferenceDDD 2023
TypePeer-reviewed article
10 May 2023 13:47
Presented ByDr Nabih Maslah, Université Paris Cité, France
ConferenceASH 2022
TypePeer-reviewed article
20 February 2023 12:43
Presented ByProf. Thierry Passeron, University Côte d’Azur, France
TrialPhase 3, TRuE-V1; TRuE-V2 ConferenceEADV 2022
TypePeer-reviewed article
5 November 2022 10:50
Presented ByProf. William Damsky, Yale School of Medicine, USA
ConferenceAAD 2022
TypePeer-reviewed article
17 May 2022 11:12
Presented ByDr David Rosmarin, Tufts Medical Center, USA
TrialPhase 3, TRuE-V1; TRuE-V2 ConferenceAAD 2022
TypePeer-reviewed article
17 May 2022 11:05
Presented ByDr Rachel Giles, Medicom
ConferenceAAD 2022
14 April 2022 11:02
Presented ByDr David Rosmarin, Tufts Medical Center Boston, USA
TrialPhase 3, TRuE-V1; TruE-V2 ConferenceEADV 2021
TypePeer-reviewed article
18 November 2021 13:27
Presented ByProf. Jacek Szepietowksi, Wroclaw Medical University, Poland
TrialPhase 3, TRuE-AD1; TRuE-AD2 ConferenceEADV 2021
TypePeer-reviewed article
18 November 2021 13:21
Presented ByProf. Francesco Passamonti, University of Insubria, Italy
TrialPERSIST; SIMPLIFY; BOREAS ConferenceEHA 2021
TypePeer-reviewed article
5 August 2021 14:54
Presented ByProf. Natasha Mesinkovska, UC Irvine School of Medicine, CA, USA
ConferenceAAD VMX 2021
TypePeer-reviewed article
7 June 2021 13:45
Presented ByProf. Robert Zeiser, University Hospital Freiburg, Germany
TrialPhase 3, REACH2 ConferenceEHA 2020
TypePeer-reviewed article
9 September 2020 09:57
Presented ByProf. Amit Pandya, University of Texas Southwestern Medical Center, USA
ConferenceEADV 2019
9 December 2019 13:08
Presented ByProf. Brett King, Yale School of Medicine, USA
ConferenceAAD 2019
TypePeer-reviewed article
19 April 2019 20:08
Presented ByProf. Eric Simpson, Oregon Health & Science University, USA
ConferenceAAD 2019
TypePeer-reviewed article
19 April 2019 14:12
Presented ByProf. John Harris, University of Massachusetts, USA
ConferenceAAD 2019
TypePeer-reviewed article
19 April 2019 13:53